Alnylam Pharmaceuticals
ALNY
#630
Rank
NZ$67.58 B
Marketcap
NZ$506.23
Share price
0.61%
Change (1 day)
10.32%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company